Inhibition of α-hemolysin activity of Staphylococcus aureus by theaflavin 3,3’-digallate
The ongoing rise in antibiotic resistance, and a waning of the introduction of new antibiotics, has resulted in limited treatment options for bacterial infections, including these caused by methicillin-resistant Staphylococcus aureus, leaving the world in a post-antibiotic era. Here, we set out to e...
Main Authors: | Anna Goc, Waldemar Sumera, Matthias Rath, Aleksandra Niedzwiecki |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470925/?tool=EBI |
Similar Items
-
Inhibitory Mechanism of Theaflavin-3,3’-digallate on α-Glucosidase
by: CAO Yufan, HUANG Wei, CHEN Quming, CAI Weirong
Published: (2024-11-01) -
Theaflavin −3,3'-digallate/ethanol: a novel cross-linker for stabilizing dentin collagen
by: Zhiyong Chen, et al.
Published: (2024-05-01) -
Improving Theaflavin-3,3′-digallate Production Efficiency Optimization by Transition State Conformation of Polyphenol Oxidase
by: Ying Huang, et al.
Published: (2023-04-01) -
Potential quorum-sensing inhibitor of Hafnia alvei H4—theaflavin-3,3´-digallate analyzed by virtual screening and molecular simulation
by: Xue Li, et al.
Published: (2023-10-01) -
β-Hemolysin, not agrA mutation, inhibits the hemolysis of α-hemolysin in Staphylococcus aureus laboratory and clinical strains
by: Lin Liu, et al.
Published: (2024-02-01)